top of page
CCCB
CELL CYCLE & CANCER BIOMARKERS LAB
CCCB RESEARCH GOALS
PERSONALIZED MEDICINE
Cancer is one of the main causes of mortality and its complexity grows as different types of cancer can be further classified into different subtypes. To deepen the knowledge concerning the molecular mechanisms associated with cancer is essential for the development of new therapeutic strategies, with the final goal to reach the concept of "personalized medicine".
(video is in Spanish)
CELL CYCLE BIOMARKERS
The CCCB laboratory main interest is focused on the cell cycle and cell division machinery and how are interconnected to cancer processes. We pursue the identification of new cancer biomarkers related to cell cycle genes, with the ultimate goal to provide new tools for cancer therapy.
DRUG SENSITIVITY & RESISTANCE MECHANISMS
Classical chemotherapy, although effective in a percentage of cases, is associated with severe cytotoxic side effects. Pharmaceutical companies are developing new inhibitors against specific cell cycle molecular targets. Unfortunately, these newly designed drugs are not as efficient as initially thought. Therefore, to identify mechanisms of sensitivity and resistance to newly cell cycle developed drugs, is of great interest to the medical community.
bottom of page